Kiniksa Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its ARCALYST injection therapy as a first-of-its-kind treatment for adults …
Regeneron announced that the US Food and Drug Administration (FDA) has approved its Evkeeza antibody as a first-of-its-kind treatment for adult and pediatric …
Regeneron announced that the US Food and Drug Administration (FDA) has approved its Inmazeb anti-viral antibody as a first-of-its-kind treatment for Ebola virus infection …
Shares in Regeneron advanced 3.5% in Wednesday’s extended market session after the company filed for Emergency Use Authorization (EUA) with the US Food …
Shares in Regeneron Pharmaceuticals are advancing 4.4% in Wednesday’s pre-market trading after the company disclosed that its investigational two-antibody cocktail, REGN-COV2, lowered viral …
Regeneron Pharmaceuticals, Inc (REGN) and Intellia Therapeutics, Inc. (NTLA) announced an expansion of their partnership to jointly develop potential products for the treatment of hemophilia …
After Roche released initially reassuring datasets for its wet AMD and DME candidate, BTIG’s Dane Leone believes this spells trouble for REGN.
In a research report sent to investors today, Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Regeneron Pharmaceuticals (NASDAQ:REGN) with a …
In a research report sent to investors today, J.P.
In a research note released this morning, Roth Capital reiterated coverage on Regeneron Pharmaceuticals (REGN) with a Buy rating and a price target of $382.00, following the announcement that …